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Direct reprogramming of somatic cells into induced pluripotent stem (iPS) cells has emerged 
as an invaluable method for generating patient-specific stem cells of any lineage without the 
use of embryonic materials. Following the first reported generation of iPS cells from murine 
fibroblasts using retroviral transduction of a defined set of transcription factors, various new 
strategies have been developed to improve and refine the reprogramming technology. Recent 
developments provide optimism that the generation of safe iPS cells without any genomic 
modification could be derived in the near future for the use in clinical settings. This review 
summarizes current and evolving strategies in the generation of iPS cells, including types of 
somatic cells for reprogramming, variations of reprogramming genes, reprogramming 
methods, and how the advancement iPS cells technology can lead to the future success of 
reproductive medicine. 
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